Alpha Mark Advisors, LLC Cara Therapeutics, Inc. Transaction History

Alpha Mark Advisors, LLC

  • $231 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 24, 2020
SELL
$9.12 - $17.78 $13,132 - $25,603
-1,440 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$16.11 - $25.98 $402 - $649
-25 Reduced 1.71%
1,440 $23,000
Q2 2018

Aug 03, 2018
BUY
$11.6 - $19.27 $290 - $481
25 Added 1.74%
1,465 $28,000
Q3 2017

Nov 02, 2017
BUY
$12.6 - $16.34 $18,144 - $23,529
1,440
1,440 $20,000

Others Institutions Holding CARA

# of Institutions
10
Shares Held
826K
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $257M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email